Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Hospital de Sabadell Corporacion Parc Tauli CIBEREHD |
---|---|
Information provided by: | Hospital de Sabadell |
ClinicalTrials.gov Identifier: | NCT00687336 |
The goal of the study is to compare the effectiveness of empirical Helicobacter pylori treatment compared with treatment depending on diagnostic tests for Helicobacter pylori in patients with Upper gastrointestinal bleeding due to peptic ulcer. Main hypothesis is that empirical treatment will reduce the number of patients lost to follow-up thus improving the cure rates of Hp infection.
Condition | Intervention | Phase |
---|---|---|
Peptic Ulcer Hemorrhage |
Other: Empirical Hp eradication Other: Eradication treatment guided by a positive test |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Phase IV Study Comparing Helicobacter Pylori Empiric Eradication With Test-Guided Treatment in Patients With Peptic Ulcer Bleeding |
Estimated Enrollment: | 178 |
Study Start Date: | May 2008 |
Estimated Study Completion Date: | May 2010 |
Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
Empirical eradication treatment
|
Other: Empirical Hp eradication
Empirical Helicobacter pylori treatment initiated immediately after oral intake is resumed
|
2: Active Comparator
Eradication treatment according to a diagnostic test (URT, histological test, breath test or serology).
|
Other: Eradication treatment guided by a positive test
Eradication treatment given if there is at least one positive diagnostic test (URT, histological test, breath test or serology) for Helicobacter pylori.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Pilar Garcia, Dra. | 34-93-723-1010 ext 20101 | pgarciai@telefonica.net |
Contact: Xavier Calvet, Dr. | 34-93-723-1010 ext 20101 | xcalvet@tauli.cat |
Spain, Barcelona | |
Hospital de Sabadell, Institut Universitari Parc Tauli | Recruiting |
Sabadell, Barcelona, Spain, 08208 |
Principal Investigator: | Pilar Garcia, Dra. | Hospital de Sabadell |
Study Chair: | Xavier Calvet, Dr. | Hospital de Sabadell |
Responsible Party: | Hospital de Sabadell ( Dr. Xavier Calvet Calvo ) |
Study ID Numbers: | CIR2007/058 |
Study First Received: | May 27, 2008 |
Last Updated: | May 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00687336 |
Health Authority: | Spain: Ethics Committee |
Helicobacter pylori Treatment Upper gastrointestinal bleeding |
Stomach Diseases Digestive System Diseases Gastrointestinal Diseases Ulcer Peptic Ulcer Hemorrhage |
Gastrointestinal Hemorrhage Intestinal Diseases Hemorrhage Duodenal Diseases Peptic Ulcer |
Pathologic Processes |